High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators.
State University of New York Health Science Center and Kings County Hospital Center, Brooklyn, NY, USA.
Karam
Jocelyne G
JG
Loney-Hutchinson
Lisel
L
McFarlane
Samy I
SI
D000328:Adult; D000069059:Atorvastatin; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002543:Cerebral Hemorrhage; D002544:Cerebral Infarction / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D002546:Ischemic Attack, Transient / Q000188:drug therapy*; D008297:Male; D011758:Pyrroles / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D012306:Risk; D020521:Stroke / Q000188:drug therapy* / Q000401:mortality
D008078:Cholesterol, LDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin